Kevin Daniels - 31 Dec 2023 Form 4/A Insider Report for Core Laboratories Inc. /DE/ (CLB)

Source evidence Original filing metadata and source links for verification. 6 source fields
SEC form
4/A
Accepted by SEC
08 Jan 2024, 14:50:15 UTC
Original report date
03 Jan 2024
Prior SEC filing
04 Dec 2023
Next SEC filing
15 Feb 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Mark Tattoli, Attorney-in-Fact

Key filing fact

Kevin Daniels filed Form 4/A for Core Laboratories Inc. /DE/ (CLB) on 08 Jan 2024.

Key facts

  • This page summarizes Kevin Daniels's Form 4/A filing for Core Laboratories Inc. /DE/ (CLB).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 08 Jan 2024, 14:50.

Change

  • Previous filing in this sequence was filed on 04 Dec 2023.
  • Current net transaction value: -$50,048.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CLB transaction

Common Stock

Tax liability

Transaction value
$50,048
Shares
-2,834
Change %
-18%
Price
$17.66
Shares after
13,115
Date
31 Dec 2023
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The original Form 4, filed on January 3, 2024, is being amended by this Form 4 amendment to correct an administrative error of the issuer, whereupon the number of shares withheld to satisfy tax withholding obligations upon vesting of certain restricted performance shares was misreported as 2,769 shares. The corrected transaction reflects an increase of 65 shares withheld by the issuer as a result such vesting and a corresponding reduction in the number of shares beneficially owned by the reporting person.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .